"The Diabetes-Endocrinology Center of WNY helps patients improve the quality of their lives and health through proper management of and education about their particular condition. Our doctors specialize in the diagnosis, management and treatment of Type I and Type II diabetes and its complications. We also treat other endocrine disorders such as thyroid disease and metabolic disorders, just to name a couple."

During the past decade, Diabetes-Endocrinology Center of WNY conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Diabetes-Endocrinology Center of WNY" #1 sponsor was "InteKrin Therapeutics, Inc." with 2 trials, followed by "University at Buffalo" with 2 trials sponsored, "Ambrilia Biopharma, Inc." with 1 trials sponsored, "Axio Research. LLC" with 1 trials sponsored and "Exsulin Corporation" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diabetes-Endocrinology Center of WNY" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Diabetes-Endocrinology Center of WNY" are "Type 1 Diabetes" (2 trials), "Acromegaly" (1 trials), "Atherosclerosis" (1 trials), "Cardiovascular Diseases" (1 trials) and "Cerebrovascular Accident" (1 trials). Many other conditions were trialed in "Diabetes-Endocrinology Center of WNY" in a lesser frequency.

Most popular intervention types in "Diabetes-Endocrinology Center of WNY" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "placebo" (2 trials), "C2L-OCT-01 PR, 10 or 20 mg" (1 trials), "C2L-OCT-01 PR, 20 mg" (1 trials) and "Extended release niacin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Diabetes-Endocrinology Center of WNY" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Diabetes-Endocrinology Center of WNY". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Diabetes-Endocrinology Center of WNY, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Diabetes-Endocrinology Center of WNY, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".